Glenmede Trust CO Na Ani Pharmaceuticals Inc Transaction History

Glenmede Trust CO Na

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$23.69 - $31.47 $1,279 - $1,699	-54 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$26.38 - $33.1 $316 - $397	-12 Reduced 18.18%	54 $1,000
Q2 2020 Aug 14, 2020	SELL	$29.93 - $50.1 $867 - $1,452	-29 Reduced 30.53%	66 $2,000
Q4 2019 Feb 12, 2020	BUY	$55.65 - $79.83 $1,613 - $2,315	29 Added 43.94%	95 $5,000
Q3 2019 Nov 14, 2019	BUY	$64.7 - $85.39 $2,070 - $2,732	32 Added 94.12%	66 $4,000
Q4 2018 Feb 14, 2019	BUY	$41.17 - $56.44 $1,399 - $1,918	34 New	34 $1,000

211

18.8M

11.7K

10.5K

Ticker ANIP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 17,426,000
Market Cap $986M
Description
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...

Get notified when there are updates to the investment portfolio of Glenmede Trust CO Na, based on Form 13F filings with the SEC.

Stay updated on Glenmede Trust CO Na with notifications on news.